pharmaceutical

Eli Lilly pulls PBS application for eczema drug

Exciting updates in rosacea management

Upadacitinib shows promise for papulopustular rosacea in pilot study

‘Major step forward’: TGA approves first pharmacological therapy for OSA

New consensus for JAKi use in AD

Oral JAKi improves phototherapy-induced repigmentation in vitiligo

Dupilumab for chronic spontaneous urticaria gets tick

Eli Lilly exec says slow PBS threatens clinical trials funding
